Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesWomens ImagingEUSOBI puts focus on assisted reproductive technologiesThere's an urgent need to cast light on the link between assisted reproductive technologies and breast cancer risk, researchers noted at the European Society of Breast Imaging (EUSOBI) annual congress.Artificial IntelligenceWill AI lead to merger of radiology and pathology?CTU.K. newspaper exposes scandal of European radiologistWomens ImagingMissed previous mammography screening linked to worse disease outcomesSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar